Angiodynamics to report fiscal 2024 third quarter financial results on april 4, 2024

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the third quarter of fiscal year 2024 before the market open on thursday, april 4, 2024. the company's management will host a conference call at 8:00 a.m. et the same day to.
ANGO Ratings Summary
ANGO Quant Ranking